Chiara Uliveto
Design and testing of novel Proteolysis-targeting chimera (PROTAC) construct for brain cancer therapy.
Rel. Jacek Adam Tuszynski, Marco Agostino Deriu. Politecnico di Torino, Corso di laurea magistrale in Ingegneria Biomedica, 2022
|
Preview |
PDF (Tesi_di_laurea)
- Tesi
Licenza: Creative Commons Attribution Non-commercial No Derivatives. Download (22MB) | Preview |
Abstract
Malignant tumors are some of the most serious diseases affecting human health, which clinical prognosis remains relatively poor. Therefore, there have been intensive efforts in the past years directed at the discovery and the development of new small molecules, which are in most cases natural compounds, capable of interfering with tubulin polymerization and therefore leading to their anticancer potential. In facts, microtubules are involved in various cellular processes such as cell division, cell motility and intracellular transport. Their essential role in cell division makes them a fundamental target for designing anti-mitotic agents. Microtubules are composed of αβ tubulin subunits that consist of various isotypes encoded by specific genes which are expressed in a tissue-specific manner.
Tubulin isotypes regulate microtubule dynamic instability, contributing to the development of drug resistance in certain types of cancers
Relatori
Anno Accademico
Tipo di pubblicazione
Numero di pagine
Corso di laurea
Classe di laurea
Ente in cotutela
Aziende collaboratrici
URI
![]() |
Modifica (riservato agli operatori) |
